SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Tacent Projects Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

531887

INE149D01011

-0.8102564

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

14.9

EPS(TTM)

Face Value()

Div & Yield %

Back

kotia enterprises ltd

Relonchem receives UK MHRA's marketing approval for two products

Nov 17,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA:

1. Mefenamic Acid 250 mg Film-Coated Tablets
2. Mefenamic Acid 500 mg Film-Coated Tablets

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)